We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC
SGMO

Delisted

SGMO was delisted on the 4th of May, 2026.

Back to rankings

99 hedge funds and large institutions have $240M invested in SANGAMO THERAPEUTICS INC in 2013 Q2 according to their latest regulatory filings, with 99 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

1,450% more call options, than puts

Call options by funds: $61.6M | Put options by funds: $3.97M

43.57% more ownership

Funds ownership: 0% → 43.57% (+44%)

Holders
99
Holders Change
+99
Holders Change %
–
% of All Funds
3.22%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
99
Increased
–
Reduced
–
Closed
–
Calls
$61.6M
Puts
$3.97M
Net Calls
+$57.6M
Net Calls Change
+$57.6M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

SGMO Hedge Fund Activity: Q2 2013 in Review

99 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q2 2013, worth a combined $240M.

Buyers outnumbered sellers: 99 funds opened new SGMO positions and 0 closed out — a net gain of 99 holders — while 0 added to existing stakes and 0 trimmed.

  • 99 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $240M of SANGAMO THERAPEUTICS INC stock for Q2 2013.
  • 99 funds opened new SANGAMO THERAPEUTICS INC positions in Q2 2013 and 0 closed out, a net change of +99 holders.

Based on aggregated 13F filings for Q2 2013.